Ticker: XBI CUSIP: 78464A870 Class: S&P BIOTECH
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 206,304 | $25,155 | — | — |
| Q4 2024 | 105,696 | $9,519 | — | — |
| Q3 2024 | 335,509 | $33,148 | — | — |
| Q4 2023 | 449,500 | $40,136 | — | — |
| Q3 2023 | 493,000 | $35,999 | — | — |
| Q2 2023 | 312,200 | $25,975 | — | — |
| Q1 2017 | 1,511,401 | $104,801 | — | — |
| Q4 2016 | 1,511,401 | $89,460 | — | — |
| Q3 2016 | 1,009,000 | $66,887 | — | — |
| Q2 2016 | 1,009,000 | $54,577 | — | — |
| Q1 2016 | 936,441 | $48,377 | — | — |
| Q4 2015 | 871,000 | $61,040 | — | — |
| Q3 2015 | 731,475 | $45,534 | — | — |
| Q2 2015 | 172,000 | $43,385 | — | — |
| Q1 2015 | 230,000 | $51,865 | — | — |
| Q4 2014 | 230,000 | $42,927 | — | — |
| Q3 2014 | 230,000 | $35,873 | — | — |
| Q2 2014 | 230,000 | $35,431 | — | — |
| Q1 2014 | 220,000 | $31,346 | — | — |
| Q4 2013 | 190,000 | $24,738 | — | — |
| Q3 2013 | 132,000 | $17,049 | — | — |
| Q2 2013 | 100,000 | $10,426 | — | — |